Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.

Ilani N, Roth MY, Amory JK, Swerdloff RS, Dart C, Page ST, Bremner WJ, Sitruk-Ware R, Kumar N, Blithe DL, Wang C.

J Clin Endocrinol Metab. 2012 Oct;97(10):3476-86. doi: 10.1210/jc.2012-1384. Epub 2012 Jul 12.

2.

Combined transdermal testosterone gel and the progestin nestorone suppresses serum gonadotropins in men.

Mahabadi V, Amory JK, Swerdloff RS, Bremner WJ, Page ST, Sitruk-Ware R, Christensen PD, Kumar N, Tsong YY, Blithe D, Wang C.

J Clin Endocrinol Metab. 2009 Jul;94(7):2313-20. doi: 10.1210/jc.2008-2604. Epub 2009 Apr 14.

3.

Acceptability of a transdermal gel-based male hormonal contraceptive in a randomized controlled trial.

Roth MY, Shih G, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Sitruk-Ware R, Blithe DL, Amory JK.

Contraception. 2014 Oct;90(4):407-12. doi: 10.1016/j.contraception.2014.05.013. Epub 2014 Jun 2.

4.

Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial.

Zitzmann M, Rohayem J, Raidt J, Kliesch S, Kumar N, Sitruk-Ware R, Nieschlag E.

Andrology. 2017 May;5(3):516-526. doi: 10.1111/andr.12328. Epub 2017 Feb 11.

PMID:
28189123
5.

Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.

Gonzalo IT, Swerdloff RS, Nelson AL, Clevenger B, Garcia R, Berman N, Wang C.

J Clin Endocrinol Metab. 2002 Aug;87(8):3562-72.

PMID:
12161475
6.

Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist.

Page ST, Amory JK, Anawalt BD, Irwig MS, Brockenbrough AT, Matsumoto AM, Bremner WJ.

J Clin Endocrinol Metab. 2006 Nov;91(11):4374-80. Epub 2006 Aug 29.

PMID:
16940442
7.

Characteristics associated with suppression of spermatogenesis in a male hormonal contraceptive trial using testosterone and Nestorone(®) gels.

Roth MY, Ilani N, Wang C, Page ST, Bremner WJ, Swerdloff RS, Dart C, Sitruk-Ware R, Kumar N, Blithe D, Amory JK.

Andrology. 2013 Nov;1(6):899-905. doi: 10.1111/j.2047-2927.2013.00135.x. Epub 2013 Sep 30.

8.

Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.

Handelsman DJ, Conway AJ, Howe CJ, Turner L, Mackey MA.

J Clin Endocrinol Metab. 1996 Nov;81(11):4113-21.

PMID:
8923869
9.

A dose-finding, cross-over study to evaluate the effect of a Nestorone®/Estradiol transdermal gel delivery on ovulation suppression in normal ovulating women.

Brache V, Merkatz R, Kumar N, Jesam C, Sussman H, Hoskin E, Roberts K, Alami M, Taylor D, Jorge A, Croxatto H, Lorange E, Mishell DR, Sitruk-Ware R.

Contraception. 2015 Oct;92(4):289-97. doi: 10.1016/j.contraception.2015.05.011. Epub 2015 May 29.

PMID:
26032952
10.

Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.

Bebb RA, Anawalt BD, Christensen RB, Paulsen CA, Bremner WJ, Matsumoto AM.

J Clin Endocrinol Metab. 1996 Feb;81(2):757-62.

PMID:
8636300
11.

Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men.

Wang C, Wang XH, Nelson AL, Lee KK, Cui YG, Tong JS, Berman N, Lumbreras L, Leung A, Hull L, Desai S, Swerdloff RS.

J Clin Endocrinol Metab. 2006 Feb;91(2):460-70. Epub 2005 Nov 8.

PMID:
16278260
12.

An initial pharmacokinetic study with a Metered Dose Transdermal Systemfor delivery of the progestogen Nestorone as a possible future contraceptive.

Fraser IS, Weisberg E, Kumar N, Kumar S, Humberstone AJ, McCrossin L, Shaw D, Tsong YY, Sitruk-Ware R.

Contraception. 2007 Dec;76(6):432-8. Epub 2007 Nov 9.

PMID:
18061700
14.

Contraceptive efficacy of a depot progestin and androgen combination in men.

Turner L, Conway AJ, Jimenez M, Liu PY, Forbes E, McLachlan RI, Handelsman DJ.

J Clin Endocrinol Metab. 2003 Oct;88(10):4659-67.

PMID:
14557437
15.

Male hormonal contraception: suppression of spermatogenesis by injectable testosterone undecanoate alone or with levonorgestrel implants in chinese men.

Gui YL, He CH, Amory JK, Bremner WJ, Zheng EX, Yang J, Yang PJ, Gao ES.

J Androl. 2004 Sep-Oct;25(5):720-7.

16.

Contraceptive efficacy and clinical performance of Nestorone implants in postpartum women.

Massai MR, Díaz S, Quinteros E, Reyes MV, Herreros C, Zepeda A, Croxatto HB, Moo-Young AJ.

Contraception. 2001 Dec;64(6):369-76.

PMID:
11834236
17.

Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men.

Behre HM, Zitzmann M, Anderson RA, Handelsman DJ, Lestari SW, McLachlan RI, Meriggiola MC, Misro MM, Noe G, Wu FC, Festin MP, Habib NA, Vogelsong KM, Callahan MM, Linton KA, Colvard DS.

J Clin Endocrinol Metab. 2016 Dec;101(12):4779-4788. Epub 2016 Oct 27.

PMID:
27788052
18.
19.

Clinical performance and menstrual bleeding patterns with three dosage combinations of a Nestorone progestogen/ethinyl estradiol contraceptive vaginal ring used on a bleeding-signaled regimen.

Weisberg E, Brache V, Alvarez F, Massai R, Mishell DR Jr, Apter D, Gale J, Sivin I, Tsong YY, Fraser IS.

Contraception. 2005 Jul;72(1):46-52.

PMID:
15964292
20.

Acceptability of a combination testosterone gel and depomedroxyprogesterone acetate male contraceptive regimen.

Amory JK, Page ST, Anawalt BD, Matsumoto AM, Bremner WJ.

Contraception. 2007 Mar;75(3):218-23. Epub 2007 Jan 16.

PMID:
17303493

Supplemental Content

Support Center